Asia Pacific Osteoarthritis Therapy Market Forecast to 2030 - Regional Analysis - by Therapy Type, Disease Indication, and End User

Description

List of Tables

The Asia Pacific osteoarthritis therapy market was valued at US$ 3,707.81 million in 2022 and is expected to reach US$ 7,037.00 million by 2030; it is estimated to register a CAGR of 8.3% from 2022 to 2030.

Innovative Therapy Options Reducing Dependency on Medications Boost Asia Pacific Osteoarthritis Therapy Market

The non-pharmacologic therapy is a key facet of treating OA. With lifestyle changes and medicines, patients suffering from OA may benefit from various supportive therapy options, including hot or cold packs and assistive devices. Additionally, complementary, and alternative therapy options such as nutritional supplements and rubefacients may help in managing OA. Further, topical treatments, supervised exercises, neuromuscular training, self-management, patient education, and weight loss intervention are among the best treatments suited for OA.

In osteoarthritis knee pain (OKP) treatment, knee braces are used to reduce knee pain as these braces may apply compression (pressure) to soft tissues, stabilize the knee, and redistribute weight. A few examples of knee braces are compression sleeves, hinged knee braces, and unloader knee braces. Also, these compression braces are easily available at drugstores, pharmacies, and online channels. Therefore, availability of innovative therapy options reduces dependency on medications, which drives the osteoarthritis therapy market growth.

Asia Pacific Osteoarthritis Therapy Market Overview

Asia Pacific osteoarthritis therapy market is segmented as China, Japan, India, Australia, South Korea, and Rest of Asia Pacific countries. The patients availability for conducting clinical trials to test drugs intended for osteoarthritis is the most influential factors responsible for market growth during the forecast period. Also, government support for conducting the patient's clinical trials further enhances the market growth during the coming years. According to the Frontiers S.A. report, with China having a high burden of an aging population, knee O.A. is the leading cause of disability, having a burden of huge healthcare costs among the Chinese population. Additionally, the National Institute of Health (NIH) reports that in rural China, symptomatic knee O.A. is more prevalent (16.57%), and this incidence has increased significantly among the population aged 70 years and older (29.25% among women and 24.71% among men). Therefore, traditional Chinese medicines (TCM) have been accepted as a complementary therapy for knee O.A. For example, acupuncture and Tai Chi are non-surgical treatment options for knee O.A. Additionally, non-pharmacological treatment options to treat knee O.A. in China emphasize a multidisciplinary approach to reduce pain and disability among the Chinese population. Non-pharmacological options include patient education, occupational and physical therapy, aerobic exercises, social support, and weight loss. Also, knee O.A. among the Chinese population is treated by pharmacological therapies such as simple and opioid analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), including COX-2 selective inhibitors, and injectable agents such as glucocorticoids and hyaluronan preparations. Therefore, the rising prevalence of knee O.A. among the aging Chinese population accelerates demand for innovative therapy options, dominating the market growth during the 2022-2030.

Asia Pacific Osteoarthritis Therapy Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Osteoarthritis Therapy Market Segmentation

The Asia Pacific osteoarthritis therapy market is categorized into therapy type, disease indications, end user, and country.

Based on therapy type, the Asia Pacific osteoarthritis therapy market is segmented into transcutaneous electrical nerve stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma (PRP) therapy & stromal vascular fraction, prolotherapy, and others. The physical therapy segment held the largest market share in 2022.

In terms of disease indications, the Asia Pacific osteoarthritis therapy market is segmented into knee osteoarthritis, spine osteoarthritis, foot and ankle osteoarthritis, shoulder osteoarthritis, hand osteoarthritis, and others. The knee osteoarthritis segment held the largest share of Asia Pacific osteoarthritis therapy market in 2022.

Based on end user, the Asia Pacific osteoarthritis therapy market is categorized into hospitals and clinics, specialty clinics, ambulatory surgical center, homecare, and others. The homecare segment held the largest share of Asia Pacific osteoarthritis therapy market in 2022.

By country, the Asia Pacific osteoarthritis therapy market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific osteoarthritis therapy market share in 2022.

Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Bioventus Inc, Omron Healthcare Inc, Exactech Inc, Medi GmbH & Co KG, and Zealmax Innovations Pvt Ltd are some of the leading companies operating in the Asia Pacific osteoarthritis therapy market.

Product Code: BMIRE00030376

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Osteoarthritis Therapy Market Landscape

4.1 Pipeline Analysis
- 4.1.1 Clinical Trial Pipeline Analysis

5. Asia Pacific Osteoarthritis Therapy Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Prevalence of Osteoarthritis
- 5.1.2 Innovative Therapy Options Reducing Dependency on Medications
5.2 Market Restraints
- 5.2.1 Product Recall
5.3 Market Opportunities
- 5.3.1 Availability of Regenerative Medicine
5.4 Future Trends
- 5.4.1 More Effective Treatment Options
5.5 Impact of Drivers and Restraints:

6. Osteoarthritis Therapy Market - Asia Pacific Market Analysis

6.1 Overview
- 6.1.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030

7. Asia Pacific Osteoarthritis Therapy Market Analysis - by Therapy Type

7.1 Overview
7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
- 7.2.1 Overview
- 7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Occupational Therapy
- 7.3.1 Overview
- 7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Physical Therapy
- 7.4.1 Overview
- 7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
- 7.5.1 Overview
- 7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Prolotherapy
- 7.6.1 Overview
- 7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Osteoarthritis Therapy Market Analysis - by Disease Indication

8.1 Overview
8.2 Knee Osteoarthritis
- 8.2.1 Overview
- 8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Spine Osteoarthritis
- 8.3.1 Overview
- 8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Foot and Ankle Osteoarthritis
- 8.4.1 Overview
- 8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Shoulder Osteoarthritis
- 8.5.1 Overview
- 8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Hand Osteoarthritis
- 8.6.1 Overview
- 8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Osteoarthritis Therapy Market Analysis - by End User

9.1 Overview
9.2 Hospitals and Clinics
- 9.2.1 Overview
- 9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Specialty Clinics
- 9.3.1 Overview
- 9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
- 9.4.1 Overview
- 9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
- 9.5.1 Overview
- 9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Osteoarthritis Therapy Market - Country Analysis

10.1 Asia Pacific Market Overview
- 10.1.1 Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.3 China: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.1.4 China: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.1.5 China: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.2 Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 Japan: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.2.4 Japan: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.2.5 Japan: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.3 India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 India: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.3.4 India: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.3.5 India: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.4 Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.3 Australia: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.4.4 Australia: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.4.5 Australia: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.5 South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.1 Overview
    - 10.1.1.5.2 South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.5.3 South Korea: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.5.4 South Korea: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.5.5 South Korea: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.6 Rest of Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.1 Overview
    - 10.1.1.6.2 Rest of Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.6.3 Rest of Asia Pacific: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.6.4 Rest of Asia Pacific: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.6.5 Rest of Asia Pacific: Osteoarthritis Therapy Market Breakdown, by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in the osteoarthritis therapy market
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 Zimmer Biomet Holdings Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 DePuy Synthes Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Bioventus Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Omron Healthcare Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Exactech Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Medi GmbH & Co KG
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Zealmax Innovations Pvt Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments

13. Appendix

13.1 About the Insight Partners